⌘K

Login Start Free

Home/Filings/5/0001209191-22-007198

5//SEC Filing

Madan Ajay 5

Accession 0001209191-22-007198

CIK 0001658247other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:26 PM ET

Size

4.9 KB

Accession

0001209191-22-007198

Insider Transaction Report

Form 5

Period: 2021-12-31

Crinetics Pharmaceuticals, Inc.CRNX

Chief Development Officer

Transactions

Other
Common Stock
2021-11-19$11.02/sh+785$8,651→ 185,456 total

Footnotes (1)

[F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

Documents

1 file

5
doc5.xmlPrimary
FORM 5 SUBMISSION

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1

filerCIK 0001807856

Filing Metadata

Form type: 5
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 4:26 PM ET
Size: 4.9 KB

View on SEC.gov